The Company
Terpenoid Therapeutics, Inc. is a drug discovery and development company focused on cancer. We use the platform of terpene chemistry to develop candidate drug molecules. Our team is creating, testing, and developing novel drug candidates using cutting-edge technologies. We seek to generate a robust pipeline of terpene-derived therapeutic agents.
Terpenoid Founders (left to right): Andrew J. Wiemer, Jeffery D. Neighbors, David F. Wiemer, Raymond J. Hohl
Terpenoid projects are built upon a fifteen-year academic collaboration of the Terpenoid founders who have expertise in the biology and chemistry of terpene metabolism, pharmacology and oncology. The company is located in the University of Iowa Technology Innovation Center in Coralville, IA. The company maintains active collaborations with the academic labs of the founders.
Terpenoid currently has two projects to discover novel drugs. One project is focused on discovering small molecule inhibitors of geranylgeranyl diphosphate synthase, a novel target with applicability towards cancer and other indications. Another project is focused on the schweinfurthins, a family of novel cytotoxic agents with applicability towards cancer.
We are working to build a successful drug discovery and development company that is capable of commercializing first-in-class drugs. We hope the compounds we bring to market can contribute to a better quality of life for patients suffering with cancer.